(Q51995538)

English

The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls.

scientific article published in March 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

author name string

Broocks A

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

Little JT

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

Martin A

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

Minichiello MD

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

Dubbert B

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

Mack C

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

Tune L

7

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

Murphy DL

8

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

Sunderland T

9

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

language of work or name

0 references

publication date

1 March 1998

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

43

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

408-416

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

Evidence for a possible functional interaction between serotonergic and cholinergic mechanisms in memory retrieval.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

The effects of p-chloroamphetamine, a depletor of brain serotonin, on the performance of rats in two types of positively reinforced complex spatial discrimination tasks

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Minaprine antagonises the serotonergic inhibitory effect of trifluoromethylphenylpiperazine (TFMPP) on acetylcholine release

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Anxiolytic potential of 5-HT3 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

The psychopharmacology of 5-HT3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Memory and cognitive function in man: Does the cholinergic system have a specific role?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Fluoxetine enhances memory processing in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

The Inhibitory Effect of Trifluoromethylphenylpiperazine on [3H]Acetylcholine Release in Guinea Pig Hippocampal Synaptosomes Is Mediated by a 5-Hydroxytryptamine1Receptor Distinct from 1A, 1B, and 1C Subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

m-Chlorophenylpiperazine as a probe of serotonin function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine. Preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Lack of evidence for Huntington's disease-like cognitive dysfunction in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

The effects of thyrotropin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Effect of specific serotonergic lesions on cholinergic neurons in the hippocampus, cortex and striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

5-HT3 antagonists in postoperative nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

A standardized set of 260 pictures: norms for name agreement, image agreement, familiarity, and visual complexity.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Serum Levels of Anticholinergic Drugs in Treatment of Acute Extrapyramidal Side Effects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Acute extrapyramidal side effects: Serum levels of neuroleptics and anticholinergics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

Search asymmetry: a diagnostic for preattentive processing of separable features.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900388-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-3223(97)00388-0

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/9532345

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51995538&oldid=1463706304"